Stay updated on STRO-002 Combo with Bevacizumab in Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the STRO-002 Combo with Bevacizumab in Ovarian Cancer Clinical Trial page.
![Latest website image capture](/pages/_next/image?url=https%3A%2F%2Fs3.us-west-2.amazonaws.com%2Fvp-files-ore%2Fresources%2F12months%2FZsts1uzuzhvn1lKEKjn1m9D8MDQ.uncropped.jpg&w=3840&q=75)
Latest updates to the STRO-002 Combo with Bevacizumab in Ovarian Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check2 days agoNo Change Detected
- Check3 days agoNo Change Detected
- Check4 days agoChange DetectedThe study has been updated to version v2.10.0 and now includes 6 locations, replacing the previous version v2.9.7.SummaryDifference0.4%
- Check5 days agoNo Change Detected
- Check11 days agoChange DetectedThe website has been updated to Revision v2.9.7 from v2.9.6.SummaryDifference0.1%
- Check16 days agoChange DetectedDifference0.3%
- Check17 days agoChange DetectedDifference0.2%
- Check24 days agoChange DetectedThe value 'Ovarian Epithelial Cancer Fallopian Tube Cancer' has been updated to 'Fallopian Tube Cancer Ovarian Epithelial Cancer'. This change represents a reversal in the order of the terms, indicating a switch in the primary focus of the study from ovarian epithelial cancer to fallopian tube cancer.SummaryDifference0.3%
- Check25 days agoChange DetectedThe value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent revision in the content of the webpage.SummaryDifference0.1%
Stay in the know with updates to STRO-002 Combo with Bevacizumab in Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the STRO-002 Combo with Bevacizumab in Ovarian Cancer Clinical Trial page.